Evidence map›Paper›PMID 35750503›Full record

ReviewGynecologic oncology2022

Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children's oncology group.

B J Dicken, D F Billmire, B Rich, F K Hazard, M Nuño, M Krailo, N Fallahazad, F Pashankar, F Shaikh, A L Frazier

Open access · greenAbstract readReview
In one paragraph

Review in Gynecologic oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Ultrasonic, Clinical, and Pathological Characteristics of Malignant Ovarian Tumors in Children.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 2 countries.

B J DickenUniversity of Alberta, Stollery Children's Hospital, Edmonton, Alberta, Canada. Electronic address: bdicken@ualberta.ca.
D F BillmireSurgery, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN, United States of America.
B RichDivision of Pediatric Surgery, Cohen Children's Hospital, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, United States of America.
F K HazardPathology and Pediatrics, Department of Pathology, Stanford University, Stanford, CA, United States of America.
M NuñoDepartment of Population and Public Health Sciences, University of Southern California, United States of America; Children's Oncology Group, Public Health Institute, United States of America.
M KrailoDepartment of Population and Public Health Sciences, University of Southern California, United States of America; Children's Oncology Group, Public Health Institute, United States of America.
N FallahazadDepartment of Pediatrics, Yale University School of Medicine, United States of America.
F PashankarDepartment of Pediatrics, Yale University School of Medicine, United States of America.
F ShaikhDivision of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
A L FrazierDana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America.
Yale University · USChildren's Oncology Group · USCohen Children's Medical Center · USDana-Farber/Boston Children's Cancer and Blood Disorders Center · USHospital for Sick Children · CAPublic Health Institute · USRiley Hospital for Children · USStanford University · USStollery Children's Hospital · CA

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

purposeIn adult women, most malignant ovarian tumors are epithelial in origin. The use of intra-operative frozen section to distinguish between benign and malignant histology is reliable in guiding operative decision-making to determine the extent of surgical staging required. Pediatric and adolescent patients with ovarian masses have a much different spectrum of pathology with most tumors arising from germ cell precursors. This review was undertaken to assess the concordance between the intra-operative frozen section and the final diagnosis as an aid to guide extent of surgical staging in a group of pediatric and adolescent patients with malignant ovarian germ cell tumors.

methodsRecords of patients aged 0 to 20 years with malignant ovarian germ cell tumors enrolled on Children's Oncology Group study AGCT0132 were reviewed. Pathology reports from patients who had both intra-operative frozen section diagnosis and final paraffin section diagnosis were compared using descriptive statistics. By inclusion criteria for the study, all patients had a final diagnosis of malignancy with required yolk sac tumor, choriocarcinoma or embryonal carcinoma histology. Available central review of pathology final paraffin section slides were compared with final institution pathology reports.

resultsOf 131 eligible patients with ovarian germ cell tumors, 60 (45.8%) had both intra-operative frozen section and final paraffin section diagnoses available. Intra-operative frozen section diagnoses were classified as: incorrect diagnosis of benign tumor (13.3%), confirmation of malignancy (61.7%), immature teratoma (16.7%), germ cell tumor not otherwise specified (5%) and no diagnosis provided (3.3%). Intra-operative frozen section was incorrect in 23 of 60 (38.3%) patients evaluated. Central pathology review was concordant with the final institution pathology diagnosis in 76.3% of patients. Central pathology review identified additional germ cell tumor components in 23.7% of patients.

conclusionsIn pediatric and adolescent patients with a confirmed final diagnosis of ovarian germ cell malignancy, intra-operative frozen section diagnosis is not reliable to inform the extent of surgical staging required. Central review by an expert germ cell tumor pathologist provides important additional information to guide therapy.

Indexed as

Neoplasms, Germ Cell and EmbryonalOvarian NeoplasmsAdolescentAdultChildFemaleFrozen SectionsHumansParaffinRetrospective StudiesTesticular NeoplasmsParaffinFrozen sectionGerm cell tumorMalignantOvary

Identifiers

PMID35750503
PMCPMC9514449
OpenAlexW4283365026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.